期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

子宫肌瘤与计划生育相关问题 被引量：1

Uterine fibroids and related aspects on family planning
原文传递
导出
摘要 子宫肌瘤是育龄妇女的常见疾病。本文就子宫肌瘤与计划生育相关问题作了阐述,强调子宫肌瘤对生育是否造成影响取决于肌瘤的大小和部位;另一方面,对患子宫肌瘤的妇女,对其可选用的各种节育方法作了评价。 Uterine fibroid was a common disease in fertile age women. Uterine fibroid and related aspects with family planning were described in this paper. It was emphasized that the size and the position of fibroids decided the effects on fertility in the patients with uterine fibroid; On the other hand, various fertility regulation methods for women with uterine fibroid were evaluated.
作者 雷贞武 杜娟
机构地区 成都中医药大学第二附属医院 四川生殖卫生医院
出处 《中国计划生育和妇产科》 2012年第3期49-51,共3页 Chinese Journal of Family Planning & Gynecotokology
关键词 子宫肌瘤 不育 计划生育 uterine fibroid subfertility family planing
分类号 R711.74 [医药卫生—妇产科学]
  • 相关文献

参考文献14

  • 1雷贞武.后天性子宫异常与复发性流产的临床问题[J].中国计划生育和妇产科,2010,2(2):72-76. 被引量：3
  • 2Casini ML, Rossi F, Agostini R, et al. Effects of the position of fibroids on fertility [ J ]. Gynecol Endocrlnol, 2006, 22: 106 - 109.
  • 3Chrisman C , Ribeiro P , Dalton VK . The levonorgestrel - releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses [ J ]. Clin Obstet Gynecol, 2007, 50 (4) : 886 -897.
  • 4Gianaroli L, Gordts S, D' Angelo A, et al. Effect of inner myometrium on reproductive outcome after IVF [ J ]. Reprod Biomed Online, 2005, 10 : 473 -477.
  • 5Klatsky PC, Lane DE, RyanIP, et al. The effect of fibroids without cavit involvement on ART outcomes independent of ovarian age [J]. Hum Reprod, 2007, 22:521 -526.
  • 6Kolankaya A, Arlci A. Myomas and assisted reproductive technologies: when and how to act[ J]. Obstet Gynecol Clin North Am, 2006, 33 : 145 - 152.
  • 7Olive DL. The surgical treatment of fibroids for infertility [ J ]. 2011, 29(2) : 113 -123.
  • 8Oliveira FG, Abdelmassih VG, Diamond MP, et al. Impact of subserosal and intramural fibroids that do not distort the endometrial cavity on the outcome of invitro fertilization Intracytoplasmic sperm injection[J]. Fertil Steril, 2004, 81:582-587.
  • 9Sayed GH , Zakherah MS , E1 - Nashar SA, et al. A randomized clinical trial of a levonorgestrel - releasing intrauterine system and a low - dose combined oral contraceptive for fibroid - related menorrhagia[ J]. Int J Gynaecol Obstet, 2011,112(2) : 126 -30.
  • 10Taylor E, Gomel V. The uterus and fertility. Fertil Steril, 2008, 89,1 -16.

二级参考文献53

  • 1陈会波,刘洪庆,李会庆,郑薇,郑国华,黄克锋.农村妇女子宫肌瘤患病现状及危险因素分析[J].中国公共卫生,2007,23(1):7-8. 被引量：14
  • 2王玮,许伟,丁淑玉,周宝森.以人群为基础子宫肌瘤危险因素病例对照研究[J].中华肿瘤防治杂志,2007,14(11):821-823. 被引量：24
  • 3Altgassen C, Kuss S, Berger U, et al. Complications in laparoscopie myomectomy[ J]. Surg Endosc,2006, 20:614 - 618.
  • 4Batra N, Khunda A, ODonovanPJ. Hysteroscopic myomectomy[ J]. Obstet Gynecol Clin North Am, 2004, 31:669 -685.
  • 5Casini ML, Rossi F, Agostini R, et al. Effects of the position of fibroids on fertility[ J]. Gynecol Endocrinol, 2006, 22:106-109.
  • 6Damiani A, Melgrati L, Franzoni G, et al. Isobaric gasless laparoscopic myomectomy for removal of large uterine leiomyomas [ J ]. Surg Endosc, 2006, 20 : 1406 - 1409.
  • 7Devi Word AS, Pham N, Arici A. Anatomic factors in recurrent pregnancy loss[ J]. Semin Reprod Med, 2006, 24:25-32.
  • 8Eisinger SH, BonglioT, FiseellaK, et al. Twelve - month safety and efficacy of low - dose mifepristone for uterine myomas[ J]. J Minim Invasive Gynecol, 2005, 12:227 - 233.
  • 9Fernandez H, AL - Najjar F, Chauvand - Lambling A, et al. Fertility after treatment of Asherman' s syndrome stage 3 and 4 [ J ]. J Minim lnvasive Gynecol, 2006, 13 : 398 - 402.
  • 10Fiscella K, Eisinger SH, MeldrumS, etal. Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial[ J]. Obstet Gynecol, 2006,108 : 1381 -1387.

共引文献6

同被引文献19

  • 1Dinger JC, Heinemann LA, Klihl - Hafaich D. The safety of adrospirenone - containing oral contraceptive : final results from theEuropean Active Survillance study on oral contraceptives based on142 475 women - years of observation[ J]. Contraception,2007,75(5) : 344-354.
  • 2Seeger JD,Lou^ilin J,Eng PM, et al. Risk of thromboembolism inwomen taking Ethinylestradiol/ drospirenone and other oralcontraceptives[ J] . Contraception, 2007,110(3 ) : 587 -593.
  • 3Parkin L, Sharpies K, Hernandez RK, et al. Risk of venousthromboembolism drospirenone or levonorgestrel : nested case -control study based on UK General Practice Research Database[ J].BMJ,2011, 340: d2139.
  • 4Jick SS, Hemades RK. Risk of non - fetal venous thromboembolismin women using oral contraceptives containing drospirenonecompared with women using oral contraceptives containiglevonorgestrel : case - control using United States claims data [ J ].BMJ, 2011,340:d2151.
  • 5Gadducci A, Barsotti C, Cosio S, et al. Smoking habit, immunesuppression,oral contraceptive use,and hormone replacementtherapy use and cervical carcinogenesis : a review of the literature[J]. Gynecol Endocrinol, 2011, 27(8) : 597 -604.
  • 6Sayed GH,Zakherah MS, El - Nashar SA, et al. A randomizedclinical trial of a levonorgestel - releasing intrauterine system andalow 一 dose combined oral contraceptive for fibroid - relatedmenorrhagia[ J]. Int J Gynecol Obsted, 2011, 112(2) : 126 - 130.
  • 7Bahamondes L, Monteiro 一 Dantas, Espejo - Arce X,et al. Aprospective study of the forearm bone density of users ofetonorgestrel — and levonorgestreal - releasing contraceptiveimplants[ J]. Hum Reprod, 2006 , 21(2) ; 466 -470.
  • 8Monteiro - Dantas C, Espejo - Arce X,Lui - Filho, et al. Athree-years longitudinal evaluation of the forearm bone density ofusers of etonogestrel - and levonorgestrel - releasing contraceptiveimplants[ J]. Reprod Health,2007,4:11.
  • 9Pongsatha S, Ekmahachai M, Suntomlimsiri N, et al. Bonemineral density in women using the subdermaJ contraceptiveimplant Implanon for at least 2 years[ J]. Int J Gynaecol Obstet,2010,109(3) : 223 -225.
  • 10HarelZ, Wolter K, Gold MA, et al. Biopsychosocial variablesassociated with substantial bone mineral density loss during the useof depot medroxyprogesterone acetate in adolescents : adolescentswho lost 5% or more from baseline vs. those who lost less than 5%[J]. Contraception, 2010, 82(6) : 503 -512.

引证文献1

二级引证文献4

中国计划生育和妇产科
2012年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部